Search for: "Apotex"
Results 521 - 540
of 1,051
Sort by Relevance
|
Sort by Date
26 Aug 2011, 3:12 pm
Apotex, No. 2010-1006 (Fed. [read post]
25 Aug 2011, 9:59 pm
Apotex, Inc. [read post]
25 Aug 2011, 4:15 pm
• Patent protection has expired in Canada and generics are available from Apotex, Sandoz and Teva, and generics have been identified in Australia despite the extended molecule patent remaining in force. [read post]
25 Aug 2011, 10:55 am
By James DeGiulio -- Allergan Secures Infringement Ruling Against Generics in Combigan Patent Suit Allergan has successfully secured an infringement ruling against Sandoz, Alcon, Apotex, and Watson Laboratories in the consolidated patent suit over four patents covering the glaucoma medication Combigan. [read post]
25 Aug 2011, 8:14 am
Apotex Corp. v. [read post]
25 Aug 2011, 8:14 am
Apotex Corp. v. [read post]
24 Aug 2011, 9:00 pm
Apotex, Inc., 470 F.3d 1368, 1375 (Fed. [read post]
16 Aug 2011, 11:35 pm
General Medicines Patent Pool faces licensing issues (Spicy IP) Australia: Pharmaceuticals – copyright in PIs and indirect patent infringement: Sanofi-Aventis Australia Pty Ltd v Apotex Pty Ltd (No 3) (Mallesons) China: One out of three seeds in China infringes patents (IP Dragon) EU: More comments to the AG opinion in Medeva (The SPC Blog) EU: Patent term extensions – uncertainty and disharmony: an overview (The SPC Blog) India: NGO alleges ‘bio-piracy’ by… [read post]
10 Aug 2011, 4:30 am
(Patent Docs) Relpax (Eletripian hydrobromide) – Pfizer settles Relpax infringement suit with Apotex (Patent Docs) Solodyn (Minocycline) – US: Medicis and Lupin settle Solodyn infringement dispute; Agree to drug development collaboration (Patent Docs) Viagra (Sildenafil citrate) – US: Patent infringement complaint filed following a Paragraph IV certification: Pfizer Inc. et al. v. [read post]
4 Aug 2011, 7:40 am
Apotex Corp., 439 F.3d 1312, 1319 (Fed. [read post]
3 Aug 2011, 3:31 am
Application fee increases by a whopping 19.4% (or almost $300K) (FDA Law Blog) US: Life sciences venture funding up 37% in second quarter (Patent Docs) Products Arava (Leflunomide) – Australia: FCA ‘evergreens’ Arava: Sanofi-Aventis Australia v Apotex (Patentology) Cambia (Diclofenac) – US: Nautilus files patent infringement complaint against Edict Pharmaceuticals in response to Para IV certification filing (Patent Docs) Cenestin – US: CAFC affirms… [read post]
1 Aug 2011, 8:41 am
Based on the above description of the present circumstances, you might think that a generic manufacturer, such as Apotex, would now have the right to market a competing leflunomide product for the purposes covered by the existing approvals, i.e. treatment of rheumatoid and psoriatic arthritis. [read post]
1 Aug 2011, 8:19 am
., Mylan Pharmaceuticals, Apotex Inc., Aurobindo Pharma Ltd., and Teva Pharmaceuticals, had filed an Abbreviated New Drug Application (ANDA) seeking to utilize Lilly's patented formula and claiming invalidity of Lilly's patent, No. 5,658,590, Treatment of attention-deficit/hyperactivity disorder, which has been issued by the US Patent Office. [read post]
27 Jul 2011, 4:06 pm
., Apotex Inc. and Impax Laborato- ries, Inc., Consumer Federation of America and National Legislative Association on Prescription Drug Prices, and Generic Pharmaceutical Association.The petition for rehearing was considered by the panel that heard the appeal, and thereafter the petition for rehearing en banc, the response to the petition, and briefs amici curiae were referred to the circuit judges who are authorized to request a poll on whether to rehear the appeal en banc. [read post]
20 Jul 2011, 4:04 am
(Spicy IP) US: Multicell Technologies receives stem cell patent (Patent Docs) US: FDA’s NDI guidance and the 18-year cycle of correcting regulatory overreach (FDA Law Blog) Products Adenoscan (Adenosine) – US: Astellas settles Adenoscan patent suit with Sagent and Strides Arcolab (Patent Docs) Angiomax (Bivalirudin) – US: The MDCO PTE decision: In play on Capitol Hill and in action at the PTO (FDA Law Blog) Cipralex (Escitalopram) – Austria: SPCs and Escitalopram in… [read post]
18 Jul 2011, 8:21 am
Apotex, Forest v. [read post]
18 Jul 2011, 8:21 am
Apotex, Forest v. [read post]
14 Jul 2011, 2:00 am
Apotex– utility of the invention must either be demonstrated or based on a “sound prediction” that it will work for its intended purpose -Best Mode Requirement – at the time of filing, did the inventor possess a best mode? [read post]
14 Jul 2011, 2:00 am
Apotex– utility of the invention must either be demonstrated or based on a “sound prediction” that it will work for its intended purpose -Best Mode Requirement – at the time of filing, did the inventor possess a best mode? [read post]
13 Jul 2011, 3:04 am
Doubtful (FDA Law Blog) US: Joint citizen petition asks FDA for clarity on off-label use manufacturer-communications (FDA Law Blog) Products Allegra (Fexofenadine) – US: Sanofi settles with Actavis in Allegra suit (Patent Docs) Aloxi (Palonosetron) – US: Roche sues Teva, Sandoz, Dr Reddy over generic Aloxi (GenericsWeb) Amrix (Cyclobenzaprine) – US: CAFC changes course, denies stay of injunction of Mylan’s generic Amrix sales: In re Cyclobenzaprine Hydrochloride… [read post]
